Gene CMO
Scope
Date
~
-
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Korean food
SK acquires 70% stake in Yposkesi to jump into cell, gene CMO business
SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...
Mar 31, 2021 (Gmt+09:00)
-
Biopharma CMO
Moderna deal shows Korea’s prowess as global hub for biopharma CMO
South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines ...
Dec 30, 2020 (Gmt+09:00)
language -
Mergers & Acquisitions
SK in talks to buy French biologics contract manufacturer
SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...
Dec 17, 2020 (Gmt+09:00)
language